AngioDynamics
ANGO
105 hedge funds and large institutions have $331M invested in AngioDynamics in 2014 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 31 increasing their positions, 47 reducing their positions, and 15 closing their positions.
23% more call options, than puts
Call options by funds: $2.04M | Put options by funds: $1.65M
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
4% less funds holding
Funds holding: 109 → 105 (-4)
12% less capital invested
Capital invested by funds: $378M → $331M (-$46.9M)
27% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 15
34% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 47
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$9.74M |
| 2 |
PGH
Partners Group Holding
Baar-Zug,
Switzerland
|
+$8.79M |
| 3 |
SAM
Sentinel Asset Management
Montpelier,
Vermont
|
+$5.31M |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$1.08M |
| 5 |
LAM
Lapides Asset Management
Greenwich,
Connecticut
|
+$1.07M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
-$4.68M |
| 2 |
DLCIG
D.L. Carlson Investment Group
Concord,
New Hampshire
|
-$1.66M |
| 3 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$1.55M |
| 4 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
-$1.06M |
| 5 |
BCM
Bluefin Capital Management
New York
|
-$900K |
ANGO Hedge Fund Activity: Q3 2014 in Review
105 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q3 2014, worth a combined $331M — down 12% from $378M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of ANGO and 11 opened new positions — a net loss of 4 holders — while 47 trimmed existing stakes and 31 added.
The largest buyer was Deerfield Management, opening a new position worth an estimated $9.74M. The largest seller was Paradigm Capital Management Inc, cutting an estimated $4.68M.
- 105 institutional investors held AngioDynamics (ANGO) as of Q3 2014, down from 109 in Q2 2014.
- Funds reported $331M of AngioDynamics stock for Q3 2014, down 12% quarter-over-quarter.
- 11 funds opened new AngioDynamics positions in Q3 2014 and 15 closed out, a net change of -4 holders.
- The largest AngioDynamics buyer in Q3 2014 was Deerfield Management, an estimated $9.74M added.
- The largest AngioDynamics seller in Q3 2014 was Paradigm Capital Management Inc, an estimated $4.68M sold.
Based on aggregated 13F filings for Q3 2014.